MX2017012073A - Compuestos de minociclina para biodefensas. - Google Patents

Compuestos de minociclina para biodefensas.

Info

Publication number
MX2017012073A
MX2017012073A MX2017012073A MX2017012073A MX2017012073A MX 2017012073 A MX2017012073 A MX 2017012073A MX 2017012073 A MX2017012073 A MX 2017012073A MX 2017012073 A MX2017012073 A MX 2017012073A MX 2017012073 A MX2017012073 A MX 2017012073A
Authority
MX
Mexico
Prior art keywords
biodefense
bacterial infection
minocycline compounds
bacterium
treating
Prior art date
Application number
MX2017012073A
Other languages
English (en)
Inventor
P Draper Michael
Ken Tanaka S
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Publication of MX2017012073A publication Critical patent/MX2017012073A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En el presente documento se dan a conocer procedimientos para tratar o prevenir una infección bacteriana en un individuo, en donde la infección bacteriana es causada por una bacteria que puede usarse como arma biológica. También se describe una composición farmacéutica que comprende el compuesto de la presente invención para tratar o prevenir una infección bacteriana en un individuo, en donde la infección bacteriana es causada por una bacteria que puede usarse como arma biológica.
MX2017012073A 2015-03-24 2016-03-23 Compuestos de minociclina para biodefensas. MX2017012073A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137719P 2015-03-24 2015-03-24
PCT/US2016/023807 WO2016154332A1 (en) 2015-03-24 2016-03-23 Minocycline compounds for biodefense

Publications (1)

Publication Number Publication Date
MX2017012073A true MX2017012073A (es) 2018-02-21

Family

ID=56977663

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012073A MX2017012073A (es) 2015-03-24 2016-03-23 Compuestos de minociclina para biodefensas.

Country Status (14)

Country Link
US (4) US20180133231A1 (es)
EP (2) EP3273968B1 (es)
JP (3) JP6826582B2 (es)
KR (2) KR102656263B1 (es)
CN (2) CN107613988A (es)
AU (4) AU2016235151A1 (es)
CA (1) CA2980727C (es)
ES (1) ES2959665T3 (es)
FI (1) FI3273968T3 (es)
HU (1) HUE063795T2 (es)
IL (1) IL254622B2 (es)
MX (1) MX2017012073A (es)
PL (1) PL3273968T3 (es)
WO (1) WO2016154332A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016154332A1 (en) * 2015-03-24 2016-09-29 Paratek Pharmaceuticals, Inc. Minocycline compounds for biodefense
JP7025702B2 (ja) * 2016-03-31 2022-02-25 日産化学株式会社 配向層形成組成物
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
SG11201903846TA (en) * 2016-11-01 2019-05-30 Paratek Pharm Innc 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
MA52980A (fr) * 2018-04-30 2021-04-28 Melinta Therapeutics Inc Procédés de traitement d'infections bactériennes à l'aide d'oritavancine
CN111484424B (zh) * 2020-04-14 2022-10-25 成都百特万合医药科技有限公司 一种合成奥马环素的方法
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
CN114591216A (zh) * 2022-02-17 2022-06-07 四川澄华生物科技有限公司 一种合成奥马环素中间体的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1301467B1 (en) 2000-07-07 2006-08-16 Trustees Of Tufts College 9-substituted minocycline compounds
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1496742B1 (en) * 2002-03-29 2010-11-24 The Research Foundation Of State University Of New York Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
US7943600B2 (en) * 2004-12-20 2011-05-17 Massachusetts Institute Of Technology Antimicrobial combination therapy
WO2007092582A2 (en) * 2006-02-08 2007-08-16 Biosynexus Incorporated Neutralization of bacterial spores
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
CA2688662A1 (en) 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
WO2009111064A2 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
EP2536408A1 (en) * 2010-02-16 2012-12-26 Wockhardt Research Centre Efflux pump inhibitors
WO2013173326A1 (en) * 2012-05-14 2013-11-21 Paratek Pharmaceuticals, Inc. Methods of using (4s,4as,5ar,12as)-4- dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
WO2016154332A1 (en) * 2015-03-24 2016-09-29 Paratek Pharmaceuticals, Inc. Minocycline compounds for biodefense

Also Published As

Publication number Publication date
EP3273968A1 (en) 2018-01-31
KR102656263B1 (ko) 2024-04-09
KR20240051297A (ko) 2024-04-19
EP4268897A3 (en) 2024-01-03
WO2016154332A1 (en) 2016-09-29
CN116392496A (zh) 2023-07-07
US20240238315A1 (en) 2024-07-18
JP2021059544A (ja) 2021-04-15
AU2016235151A1 (en) 2017-10-12
AU2020260450B2 (en) 2022-07-21
JP2018509475A (ja) 2018-04-05
ES2959665T3 (es) 2024-02-27
EP3273968A4 (en) 2018-11-14
US20200330489A1 (en) 2020-10-22
IL254622B1 (en) 2023-09-01
PL3273968T3 (pl) 2024-01-03
AU2024202788A1 (en) 2024-05-23
CA2980727A1 (en) 2016-09-29
EP4268897A2 (en) 2023-11-01
CN107613988A (zh) 2018-01-19
AU2022256106A1 (en) 2022-11-24
HUE063795T2 (hu) 2024-01-28
JP2023022179A (ja) 2023-02-14
IL254622B2 (en) 2024-01-01
CA2980727C (en) 2023-09-19
EP3273968B1 (en) 2023-07-19
AU2020260450A1 (en) 2020-12-03
KR20170138439A (ko) 2017-12-15
US20180133231A1 (en) 2018-05-17
US11129839B2 (en) 2021-09-28
JP6826582B2 (ja) 2021-02-03
IL254622A0 (en) 2017-11-30
US20230098554A1 (en) 2023-03-30
FI3273968T3 (fi) 2023-10-09

Similar Documents

Publication Publication Date Title
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
MX2017012073A (es) Compuestos de minociclina para biodefensas.
EA201891970A1 (ru) Композиции, содержащие бактериальные штаммы
PH12016501577A1 (en) Monobactam organic compounds for the treatment of bacterial infections
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
PH12016501254A1 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ724798A (en) Polymyxin derivatives as antimicrobial compounds
MX2016010451A (es) Benzoxaboroles microbicidamente activos.
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
AU2015352440B2 (en) Compounds
PH12016501988A1 (en) Antibacterial compounds
NZ741027A (en) Antimicrobial polymyxin derivative compounds
ZA202002093B (en) Antibacterial compounds
NZ735398A (en) Novel n-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.